Recent studies showed that IGF2BP2 enhances the expression of MYC, glutamic pyruvate transaminase 2 (GPT2), and solute carrier family 1 member 5 (SLC1A5), thus promoting Gln metabolism in AML.398. Here, SLC1A5 is linked to acute myeloid leukemia.